After oral administration, the drug reaches peak plasma concentration in patients within 2–6 hours. Platelet counts begin to increase within 1–2 weeks···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 110
According to research data:In healthy volunteers taking standard doses, the half-life of the drug (time required for the concentration in the body to ···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 106
Currently, there is no established treatment plan for an overdose of this medication. According to early studies: When healthy individuals took a sing···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 106
The medication should be taken at a fixed time every day. If the forgotten time is less than 12 hours, you can take the missed dose immediately. If th···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 108
In healthy individuals taking the drug on an empty stomach, it is rapidly absorbed, typically reaching peak concentration in the blood between half an···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 106
Approval AnnouncementNovember 20, 2015 -- Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two ···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 138
Study Overview and Release ContextTakeda Pharmaceutical Company Limited, a Japanese pharmaceutical enterprise, recently announced the results of two c···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 130
Overview of Empliciti Triple TherapyEmpliciti is a multiple myeloma therapy developed by Bristol-Myers Squibb (BMS). The U.S. regulatory authorities h···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 109
Approval OverviewRecently, the Committee for Medicinal Products for Human Use (CHMP) of the European Union has granted a positive opinion for the trip···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 114
Approval AnnouncementMay 25, 2020 — Bristol-Myers Squibb (BMS) recently announced that the U.S. Food and Drug Administration (FDA) has approved Pomaly···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 147
Taking pomalidomide with other drugs that cause dizziness or confusion can worsen these effects. Ask your doctor before using opioid medication, a sle···【Read More】
Update: 2026-03-17Source: Haiou HealthViews: 127
Do not donate blood or sperm while you are using pomalidomide.Avoid driving or hazardous activity until you know how pomalidomide will affect you. You···【Read More】
Update: 2026-03-17Source: Haiou HealthViews: 123
Use the medicine as soon as you can, but skip the missed dose if you are more than 12 hours late for the dose. Do not use two doses at one time.【Read More】
Update: 2026-03-17Source: Haiou HealthViews: 137
Pomalidomide is used to treatmultiple myeloma(cancer resulting from a progressive blood disease). Pomalidomide is usually given after at least two oth···【Read More】
Update: 2026-03-17Source: Haiou HealthViews: 111
A very small number of patients may develop Posterior Reversible Encephalopathy Syndrome (PRES), a neurological disorder that can trigger seizures, hy···【Read More】
Update: 2026-03-17Source: Haiou HealthViews: 118
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



